LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 62 filers reported holding LYRA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $16,023,298 | +18.7% | 2,576,093 | +0.0% | 0.76% | -17.7% |
Q4 2023 | $13,496,107 | +273.5% | 2,575,593 | +178.7% | 0.93% | +143.7% |
Q3 2023 | $3,613,505 | -4.9% | 924,170 | 0.0% | 0.38% | -37.4% |
Q2 2023 | $3,798,339 | +104.5% | 924,170 | 0.0% | 0.61% | +67.2% |
Q1 2023 | $1,857,582 | -36.0% | 924,170 | 0.0% | 0.36% | -25.8% |
Q4 2022 | $2,901,894 | -37.3% | 924,170 | 0.0% | 0.49% | -31.5% |
Q3 2022 | $4,630,000 | -11.3% | 924,170 | 0.0% | 0.71% | -30.5% |
Q2 2022 | $5,222,000 | – | 924,170 | – | 1.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 3,222,560 | $12,955,000 | 0.26% |
Ikarian Capital, LLC | 422,338 | $1,698,000 | 0.22% |
PURA VIDA INVESTMENTS, LLC | 520,544 | $2,093,000 | 0.07% |
Clearline Capital LP | 119,924 | $482,000 | 0.06% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 66,900 | $269,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 38,516 | $155,000 | 0.00% |
Pentwater Capital Management LP | 60,000 | $241,000 | 0.00% |
Worth Asset Management, LLC | 650 | $3,000 | 0.00% |
Close Asset Management Ltd | 7,000 | $30,000 | 0.00% |
OSAIC HOLDINGS, INC. | 500 | $2,000 | 0.00% |